SHE:002317 Market Cap

SHE:002317 has a market cap or net worth of 16.11 billion as of February 23, 2026. Its market cap has increased by 67.00% in one year.

Market Cap

16.11B

Enterprise Value

15.36B

Revenue

2.45B

Ranking

n/a

PE Ratio

n/a

Stock Price

19.05

Market Cap Chart

Since December 11, 2009, SHE:002317's market cap has increased from 7.22B to 16.11B, an increase of 123.23%. That is a compound annual growth rate of 5.09%.

Market Cap History

Date	Market Cap	% Change
Feb 13, 2026	16.11B	-0.16%
Dec 31, 2025	16.13B	56.94%
Dec 31, 2024	10.28B	-24.46%
Dec 29, 2023	13.61B	-37.64%
Dec 30, 2022	21.82B	126.34%
Dec 31, 2021	9.64B	8.90%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Tonghua Dongbao Pharmaceutical	16.91B
Shenzhen Kangtai Biological Products	16.59B
Hybio Pharmaceutical	16.16B
Shenzhen Hepalink Pharmaceutical Group	16.08B
Wedge Industrial	15.89B
Nanjing King-Friend Biochemical Pharmaceutical	15.88B
Guobang Pharma	15.79B
China Resources Jiangzhong Pharmaceutical Co.,Ltd	15.69B

Market Cap Rankings